Testing a new drug for high blood pressure
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a new medicine called SPC1001 Low to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure with no known cause). If you are between 19 and 75 years old and have mild to moderate high blood pressure, this study might be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old.
- You have been diagnosed with essential hypertension (high blood pressure with no clear cause).
- Your blood pressure is not extremely high (systolic under 180 mmHg and diastolic under 110 mmHg).
- You are able to attend screening and follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an experimental drug, QLS1410, to see if it can lower blood pressure in people whose blood pressure is still high even after taking two or more medications.
This trial tests an oral medication called SPC1001 to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure not caused by another condition). It may help if you have mild to moderate high blood pressure.
This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
This study tests a new combination blood pressure medicine (HCP1803-4) for people with essential hypertension. It aims to see if the medicine works better than current options and is safe for long-term use.
This trial tests a new combination blood pressure medicine called CKD-202A. It is for adults with high blood pressure who have not had other treatments or conditions that could affect the results.
Hear when a new Hypertension (HTN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.